Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Glyphosate Cancer Claims Disputed By European Regulators November 13, 2015 Irvin Jackson Add Your CommentsA group of European regulators says it is unlikely that side effects of glyphosate, the active ingredient in Monsanto’s Roundup weed killer, causes cancer. However, the group has also recommended an exposure threshold for human safety, and proposed new controls to keep the chemical’s residue out of food.ย The European Food Safety Authority (EFSA) announced the findings of a re-assessment of glyphosate on November 12, determining that the chemical is unlikely to be carcinogenic.The findings contradict those of the World Health Organization’s International Agency for Research on Cancer (IARC), which issued a warning in March that glyphosate was a probable carcinogen.ROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONROUNDUP LAWSUITSWere you or a loved one exposed to RoundUp?Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe warning led the EFSA to review glyphosate and update the chemical’s toxicological profile. However, a peer review by EFSA scientists and representatives from health agencies throughout the European Union member states failed to link the glyphosate exposure and cancer, indicating that it is unlikely to pose a carcinogenic threat to humans, and was unlikely to damage DNA.According to the EFSA, the review included the IARC study and a large number of studies not reviewed by the IARC. However, the EFSA did set an acute reference dose (ARfD) for glyphosate of 0.5 mg per kg of body weight, which is the first time an exposure threshold has been applied to the chemical. The authority indicated that this will control the amount of residue allowed in food.The EFSA’s findings are not binding on the EU member states, and each will use the authority’s recommendations to make their own conclusions about glyphosate safety. The European Commission will also make a determination on whether to keep glyphosate on the EU list of approved active substances.“This has been an exhaustive process — a full assessment that has taken into account a wealth of new studies and data,” Jose Tarazona, head of EFSA’s Pesticides Unit, said in a press release. “By introducing an acute reference dose we are further tightening the way potential risks from glyphosate will be assessed in the future.”Roundup is one of the most widely used herbicides, which was introduced by Monsanto in the 1970s.ย A recent report on glyphosate usage by the U.S. Geological Survey foundย that an estimated 2.6 billion pounds of the herbicide has been used on Americaโs agricultural land over the two decades since the mid-1990s, when Monsanto introduced โRoundup Readyโ crops that are designed to survive being sprayed with glyphosate, killing the weeds but not the crops.Genetically modified crops, like corn and soybean, are branded as being โRoundup Ready.โ However, as some weeds have developed resistance to glyphosate, it has forced farmers to use higher and higher quantities of Roundup.The U.S. Environmental Protection Agency (EPA) announced in April that it plans to address the safety concerns of glyphosate during the regular EPA safety review hearing occurring soon. Researchers warn pesticides are commonly detected in the air, food and water near areas that have been sprayed.In the meantime, Monsanto now faces a growing number of glyphosate cancer lawsuits filed on behalf of farm workers, landscapers and other agricultural workers who have been diagnosed with non-Hodgkin lymphoma following heavy exposure to Roundup. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, RoundupMore Roundup Lawsuit Stories Roundup Cancer Lawsuit Trial Underway in Missouri Court October 5, 2026 U.S. Supreme Court Blocks Roundup Lawsuits Over Non-Hodgkin’s Lymphoma Warnings June 25, 2026 Roundup Class Action Lawsuit Linked to $7.2B NHL Settlement Transferred to Federal MDL June 2, 2026 0 Comments NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Neurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (Posted: today)A womanโs lawsuit claims prolonged use of gabapentin to treat nerve pain resulted in significant memory problems, cognitive decline and early-onset dementia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUIT FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk (Posted: yesterday)Federal regulators are requiring all GLP-1 medications to carry new label warnings indicating the side effects could put patients at risk of sudden and permanent vision loss.MORE ABOUT: OZEMPIC LAWSUITOzempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks (10/30/2026)GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind (10/13/2026)Ozempic Injection Lawsuit Claims Diabetes Medication Caused Vision Loss (09/22/2026) Consolidated Lawsuit Over Boston Scientific Spinal Cord Stimulator Problems Filed in MDL (Posted: yesterday)Individuals involved in Boston Scientific SCS implant lawsuits have submitted a Master Complaint that would help streamline future filing.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITAbbott Sales Reps Kept Trying to Reprogram Failed SCS Implant: Lawsuit (11/02/2026)Abbott Proclaim Elite Lawsuit Alleges Spinal Cord Stimulator Malfunction Worsened Chronic Pain (10/29/2026)Boston Scientific Spectra WaveWriter Lawsuit Alleges Lead Fracture, Migration and Painful Electric Shocks (10/21/2026)
Neurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (Posted: today)A womanโs lawsuit claims prolonged use of gabapentin to treat nerve pain resulted in significant memory problems, cognitive decline and early-onset dementia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUIT
FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk (Posted: yesterday)Federal regulators are requiring all GLP-1 medications to carry new label warnings indicating the side effects could put patients at risk of sudden and permanent vision loss.MORE ABOUT: OZEMPIC LAWSUITOzempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks (10/30/2026)GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind (10/13/2026)Ozempic Injection Lawsuit Claims Diabetes Medication Caused Vision Loss (09/22/2026)
Consolidated Lawsuit Over Boston Scientific Spinal Cord Stimulator Problems Filed in MDL (Posted: yesterday)Individuals involved in Boston Scientific SCS implant lawsuits have submitted a Master Complaint that would help streamline future filing.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITAbbott Sales Reps Kept Trying to Reprogram Failed SCS Implant: Lawsuit (11/02/2026)Abbott Proclaim Elite Lawsuit Alleges Spinal Cord Stimulator Malfunction Worsened Chronic Pain (10/29/2026)Boston Scientific Spectra WaveWriter Lawsuit Alleges Lead Fracture, Migration and Painful Electric Shocks (10/21/2026)